Skip to content
TrialScanner

NCT04623671

Intravenous Infusion of CAP-1002 in Patients With COVID-19

Phase 2CompletedCAPRLead

Registry record

Lead sponsor
Capricor Inc.
Conditions
Covid19
Primary completion
Feb 4, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04623671 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04623671: Intravenous Infusion of... | TrialScanner